Mirabella Financial Services LLP grew its position in Amdocs Limited (NASDAQ:DOX - Free Report) by 204.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 14,302 shares of the technology company's stock after purchasing an additional 9,600 shares during the quarter. Mirabella Financial Services LLP's holdings in Amdocs were worth $1,250,000 as of its most recent SEC filing.
A number of other large investors also recently made changes to their positions in DOX. Boston Trust Walden Corp boosted its stake in shares of Amdocs by 17.0% in the second quarter. Boston Trust Walden Corp now owns 618,387 shares of the technology company's stock valued at $48,803,000 after buying an additional 89,726 shares during the period. SG Americas Securities LLC increased its position in shares of Amdocs by 402.4% in the second quarter. SG Americas Securities LLC now owns 154,968 shares of the technology company's stock worth $12,230,000 after purchasing an additional 124,122 shares during the period. Sargent Investment Group LLC acquired a new position in Amdocs in the second quarter valued at about $289,000. BDF Gestion bought a new stake in Amdocs during the second quarter worth about $833,000. Finally, Raymond James & Associates grew its stake in Amdocs by 15.8% during the second quarter. Raymond James & Associates now owns 457,477 shares of the technology company's stock worth $36,104,000 after buying an additional 62,460 shares in the last quarter. Institutional investors own 92.02% of the company's stock.
Wall Street Analyst Weigh In
A number of analysts have recently weighed in on the stock. Barclays cut their price target on shares of Amdocs from $113.00 to $111.00 and set an "overweight" rating for the company in a report on Thursday, November 14th. Stifel Nicolaus began coverage on Amdocs in a report on Wednesday, October 2nd. They set a "buy" rating and a $100.00 price target for the company. StockNews.com lowered Amdocs from a "strong-buy" rating to a "buy" rating in a research note on Thursday, November 14th. Finally, Oppenheimer increased their target price on shares of Amdocs from $98.00 to $105.00 and gave the stock an "outperform" rating in a report on Wednesday, November 13th. One analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat.com, Amdocs presently has a consensus rating of "Moderate Buy" and an average price target of $101.83.
View Our Latest Report on Amdocs
Amdocs Stock Up 1.9 %
NASDAQ DOX traded up $1.63 on Monday, reaching $87.30. The company had a trading volume of 823,360 shares, compared to its average volume of 682,111. The company has a quick ratio of 1.24, a current ratio of 1.20 and a debt-to-equity ratio of 0.21. The stock has a market capitalization of $10.26 billion, a P/E ratio of 20.63, a P/E/G ratio of 1.43 and a beta of 0.74. The company's fifty day moving average is $88.03 and its 200 day moving average is $83.94. Amdocs Limited has a 52-week low of $74.41 and a 52-week high of $94.04.
Amdocs Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be paid a dividend of $0.479 per share. This represents a $1.92 dividend on an annualized basis and a dividend yield of 2.19%. The ex-dividend date of this dividend is Tuesday, December 31st. Amdocs's payout ratio is 45.05%.
Amdocs Profile
(
Free Report)
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Read More
Before you consider Amdocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.
While Amdocs currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.